India Bans 16 Irrational FDCs in Pharma Recalibration
India bans 16 fixed-dose combination drugs lacking therapeutic justification, following Supreme Court directives and expert reviews, aiming to curb antimicrobial resistance and promote evidence-based prescribing.


